secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2026-08-05T20:16:31+00:00
Accession:  0001628280-26-053378
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics updates corporate presentation for investor meetings; no specific new data disclosed
--------------------------------------------------------------------------------

- Filed an 8-K on August 5, 2026, to furnish an updated corporate presentation as Exhibit 99.1.
- Presentation titled 'Advancing T Cell Engagers for Solid Tumors' but full content not provided in filing.
- No financial results, clinical data, or material events announced in the 8-K body.
- Routine FD disclosure; presentation used for meetings with investors and analysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026053378/0001628280-26-053378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026053378/cntx-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-053378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer